je.st
news
Tag: merck
Merck to Present at the 31st Annual J.P. Morgan Healthcare Conference
2013-01-04 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's chairman and chief executive officer, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on January 7 at 4:00 p.m. PST (7:00 p.m. EST). Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449orInvestor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: present
annual
conference
morgan
Merck Announces FDA Acknowledgement of Resubmission of New Drug Application for Ezetimibe/Atorvastatin Tablets
2013-01-02 22:45:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin tablets, an investigational combination medicine. The updated NDA was deemed complete for review after Merck submitted additional data in response to the FDAs Complete Response Letter issued last year. Language: English Contact HTML: MerckMedia:Pamela Eisele, 908-423-5042orSkip Irvine, 267-305-5397orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
drug
announces
tablets
Merck to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
2013-01-02 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's chairman and chief executive officer, is scheduled to present at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top meeting in New York City on Thursday, Jan. 3 at 8:45 a.m. EST. Language: English Contact HTML: MerckMediaRon Rogers, 908-423-6449orInvestorsCarol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck Announces Fourth-Quarter 2012 Sales and Earnings Conference Call
2013-01-02 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter 2012 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Friday, Feb. 1. During the call, Kenneth C. Frazier, chairman and chief executive officer; Peter N. Kellogg, executive vice president and chief financial officer; and Adam H. Language: English Contact HTML: MerckMediaRon Rogers, 908-423-6449orInvestorsCarol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: call
sales
conference
earnings
Sites : [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138]